Status:
COMPLETED
Emla-Cream as Pain Relief During Pneumococcal Vaccination
Lead Sponsor:
Beatrice Olsson Duse
Conditions:
Children
Pain
Eligibility:
All Genders
2-4 years
Phase:
NA
Brief Summary
The aim of this intervention study is to compare the efficacy of Emla cream as a pain relief or no pain relief in connection to the first pneumococcal vaccination at the age of three months in Child h...
Detailed Description
The aim of this intervention study is to compare the efficacy of Emla cream as a pain relief or no pain relief in connection to the first pneumococcal vaccination at the age of three months in Child h...
Eligibility Criteria
Inclusion
- Healthy children, born vaginally or by cesarean section after 37 weeks of gestation, who were not admitted to the neonatal unit. Children should only have been with the newborn screening performed routinely at the hospital.
Exclusion
- Baby delivered by vacuum extraction or forceps. Children born before gestational week 37. Children in neonatal care and subjected to other testing than newborn screening. Shoulder dystocia. Children susceptible to methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia. Children with atopic dermatitis.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01802086
Start Date
May 1 2013
End Date
November 1 2015
Last Update
October 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Healthcare center Mariefred/Strängnäs
Mariefred, Sweden, 64723